![Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines](https://www.mdpi.com/vaccines/vaccines-10-00099/article_deploy/html/images/vaccines-10-00099-g018.png)
Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
![IgM Immunoglobulin Influences Recovery after Cervical Spinal Cord Injury by Modulating the IgG Autoantibody Response | eNeuro IgM Immunoglobulin Influences Recovery after Cervical Spinal Cord Injury by Modulating the IgG Autoantibody Response | eNeuro](https://www.eneuro.org/content/eneuro/8/5/ENEURO.0491-19.2021/F1.large.jpg)
IgM Immunoglobulin Influences Recovery after Cervical Spinal Cord Injury by Modulating the IgG Autoantibody Response | eNeuro
![Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines](https://www.mdpi.com/vaccines/vaccines-10-00099/article_deploy/html/images/vaccines-10-00099-g010.png)
Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
![Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells](https://www.frontiersin.org/files/Articles/713704/fimmu-12-713704-HTML-r1/image_m/fimmu-12-713704-g001.jpg)
Frontiers | IgG Immune Complexes Inhibit Naïve T Cell Proliferation and Suppress Effector Function in Cytotoxic T Cells
![IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death | Stroke IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death | Stroke](https://www.ahajournals.org/cms/asset/7ba547dd-2d45-4f18-8e35-a332c76192c2/hs0970382001.jpeg)
IgG Anticardiolipin Antibody Titer >40 GPL and the Risk of Subsequent Thrombo-occlusive Events and Death | Stroke
![Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020](https://www.frontiersin.org/files/Articles/535396/fimmu-11-01301-HTML/image_m/fimmu-11-01301-g001.jpg)
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020
Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants | Journal of the American Chemical Society
![Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-023-02335-3/MediaObjects/41398_2023_2335_Fig1_HTML.png)
Maternal brain reactive antibodies profile in autism spectrum disorder: an update | Translational Psychiatry
Elevation of Matrix Metalloproteinase-9 Level in Cerebrospinal Fluid of Tick-Borne Encephalitis Patients Is Associated with IgG Extravassation and Disease Severity | PLOS ONE
![Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency](https://pub.mdpi-res.com/curroncol/curroncol-30-00022/article_deploy/html/images/curroncol-30-00022-g001.png?1671951236)
Current Oncology | Free Full-Text | A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
![Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population](https://pub.mdpi-res.com/vaccines/vaccines-09-00999/article_deploy/html/images/vaccines-09-00999-g001b.png?1631162858)
Vaccines | Free Full-Text | IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population
![Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020 Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020](https://www.mdpi.com/microorganisms/microorganisms-09-00850/article_deploy/html/images/microorganisms-09-00850-g001-550.jpg)
Microorganisms | Free Full-Text | SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
![SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according](https://minio.scielo.br/documentstore/1678-4774/yLGR3jGqYxbmLFyjX6X6vzk/903d16d2914f825ebadff2b7ecdcef6a51b4b870.png)
SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according
![Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines](https://pub.mdpi-res.com/vaccines/vaccines-10-00099/article_deploy/html/images/vaccines-10-00099-g012.png?1641807032)
Vaccines | Free Full-Text | Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
![Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science](https://www.science.org/cms/10.1126/science.abe9728/asset/751ba264-469e-4144-b895-27350df5b8af/assets/graphic/371_288_f1.jpeg)
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic | Science
![SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according](https://minio.scielo.br/documentstore/1678-4774/yLGR3jGqYxbmLFyjX6X6vzk/8237c3239867af75c7ae2e6b142d386e3aae6f15.png)
SciELO - Brasil - Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according
![Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases](https://www.frontiersin.org/files/Articles/696003/fimmu-12-696003-HTML-r1/image_m/fimmu-12-696003-g001.jpg)
Frontiers | Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
![Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells | Cell Death Discovery Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells | Cell Death Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41420-021-00781-w/MediaObjects/41420_2021_781_Fig1_HTML.png)